4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-013701
Chief Development Officer sold 238 shares at $10.71 ($2,549)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Development Officer | 2023-04-18 | Sale | −238 | $10.71 | $2,549 | 90,879 | D |
| Open-market sales · 238 sh · avg $10.71 · $2,549 | |||||||
Loading xslF345X04/ownership.xml…